Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Novella Romanelli

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Pharmacological Research|September 21, 2021
Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunitiesMaria Novella Romanelli, Vittoria Borgonetti, Nicoletta Galeotti
Current Drug Targets|June 2, 2015
Updates on HCN Channels in the Heart: Function, Dysfunction and PharmacologyLaura Sartiani, Maria Novella Romanelli, Alessandro Mugelli, et al.
Current Pharmaceutical Design|January 29, 2002
Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugsFulvio Gualtieri, Dina Manetti, Maria Novella Romanelli, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulatorsSilvia Dei, Laura Braconi, Maria Novella Romanelli, et al.
Metabolites|May 26, 2018
Amino Acids as Building Blocks for Carbonic Anhydrase InhibitorsNiccolò Chiaramonte, Maria Novella Romanelli, Elisabetta Teodori, et al.
Pharmacology, Biochemistry, and Behavior|August 20, 2017
The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse modelMaria Domenica Sanna, Luca Guandalini, Maria Novella Romanelli, et al.
Canadian Journal of Physiology and Pharmacology|July 4, 2018
Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitabilityValentina Spinelli, Laura Sartiani, Alessandro Mugelli, et al.
Journal of Cellular and Molecular Medicine|November 8, 2014
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosisManjola Balliu, Luca Guandalini, Maria Novella Romanelli, et al.
Current Topics in Medicinal Chemistry|October 26, 2022
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) ReversersElisabetta Teodori, Laura Braconi, Dina Manetti, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 2, 2022
Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve InjuryVittoria Borgonetti, Elisabetta Meacci, Federica Pierucci, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Pharmacological Research|September 21, 2021
Dual BET/HDAC inhibition to relieve neuropathic pain: Recent advances, perspectives, and future opportunitiesMaria Novella Romanelli, Vittoria Borgonetti, Nicoletta Galeotti
Current Drug Targets|June 2, 2015
Updates on HCN Channels in the Heart: Function, Dysfunction and PharmacologyLaura Sartiani, Maria Novella Romanelli, Alessandro Mugelli, et al.
Current Pharmaceutical Design|January 29, 2002
Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugsFulvio Gualtieri, Dina Manetti, Maria Novella Romanelli, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulatorsSilvia Dei, Laura Braconi, Maria Novella Romanelli, et al.
Metabolites|May 26, 2018
Amino Acids as Building Blocks for Carbonic Anhydrase InhibitorsNiccolò Chiaramonte, Maria Novella Romanelli, Elisabetta Teodori, et al.
Pharmacology, Biochemistry, and Behavior|August 20, 2017
The new HDAC1 inhibitor LG325 ameliorates neuropathic pain in a mouse modelMaria Domenica Sanna, Luca Guandalini, Maria Novella Romanelli, et al.
Canadian Journal of Physiology and Pharmacology|July 4, 2018
Hyperpolarization-activated cyclic-nucleotide-gated channels: pathophysiological, developmental, and pharmacological insights into their function in cellular excitabilityValentina Spinelli, Laura Sartiani, Alessandro Mugelli, et al.
Journal of Cellular and Molecular Medicine|November 8, 2014
HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosisManjola Balliu, Luca Guandalini, Maria Novella Romanelli, et al.
Current Topics in Medicinal Chemistry|October 26, 2022
The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) ReversersElisabetta Teodori, Laura Braconi, Dina Manetti, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 2, 2022
Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve InjuryVittoria Borgonetti, Elisabetta Meacci, Federica Pierucci, et al.
Pageof 10